Envestnet Asset Management Inc. Has $3.80 Million Stake in Teleflex Incorporated $TFX

Envestnet Asset Management Inc. reduced its stake in Teleflex Incorporated (NYSE:TFX) by 33.9% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 32,062 shares of the medical technology company’s stock after selling 16,429 shares during the quarter. Envestnet Asset Management Inc. owned 0.07% of Teleflex worth $3,795,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in TFX. Thurston Springer Miller Herd & Titak Inc. raised its stake in shares of Teleflex by 242.9% in the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 216 shares of the medical technology company’s stock valued at $26,000 after purchasing an additional 153 shares during the period. Banque Cantonale Vaudoise acquired a new position in shares of Teleflex during the first quarter worth about $27,000. Costello Asset Management INC bought a new position in shares of Teleflex during the first quarter worth about $28,000. Brooklyn Investment Group raised its position in Teleflex by 258.6% in the 1st quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company’s stock valued at $29,000 after buying an additional 150 shares during the last quarter. Finally, Allworth Financial LP lifted its stake in Teleflex by 504.8% in the 1st quarter. Allworth Financial LP now owns 254 shares of the medical technology company’s stock valued at $34,000 after acquiring an additional 212 shares in the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on TFX. Zacks Research downgraded Teleflex from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 30th. Royal Bank Of Canada reduced their target price on shares of Teleflex from $135.00 to $120.00 and set a “sector perform” rating for the company in a report on Friday, November 7th. Mizuho raised their target price on shares of Teleflex from $130.00 to $135.00 and gave the company a “neutral” rating in a research report on Friday, August 1st. Wells Fargo & Company lowered their price target on shares of Teleflex from $131.00 to $114.00 and set an “equal weight” rating on the stock in a research note on Friday, November 7th. Finally, Truist Financial reduced their price objective on shares of Teleflex from $128.00 to $120.00 and set a “hold” rating for the company in a research note on Monday, November 10th. One investment analyst has rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Reduce” and an average price target of $134.57.

Teleflex Price Performance

Shares of TFX opened at $106.94 on Friday. The company has a current ratio of 2.41, a quick ratio of 1.44 and a debt-to-equity ratio of 0.42. The company’s fifty day simple moving average is $123.84 and its 200 day simple moving average is $122.28. Teleflex Incorporated has a 1-year low of $102.58 and a 1-year high of $195.47. The company has a market cap of $4.73 billion, a price-to-earnings ratio of 25.16, a PEG ratio of 1.79 and a beta of 1.05.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, November 6th. The medical technology company reported $3.67 EPS for the quarter, beating analysts’ consensus estimates of $3.38 by $0.29. The company had revenue of $892.90 million during the quarter, compared to the consensus estimate of $892.79 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The company’s quarterly revenue was up 19.4% on a year-over-year basis. During the same quarter last year, the firm posted $3.49 EPS. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. On average, research analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 15th. Shareholders of record on Friday, November 14th will be given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date of this dividend is Friday, November 14th. Teleflex’s payout ratio is -18.50%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.